Literature DB >> 19569252

Conditional relative survival of cancer patients and conditional probability of death: a French National Database analysis.

Anne-Marie Bouvier1, Laurent Remontet, Guy Hédelin, Guy Launoy, Valérie Jooste, Pascale Grosclaude, Aurélien Belot, Brigitte Lacour, Jacques Estève, Nadine Bossard, Jean Faivre.   

Abstract

BACKGROUND: Little information is available on the conditional probabilities of death among patients who survive for >5 years after a diagnosis with cancer. The objective of this study was to estimate the conditional probabilities of death for breast cancer, prostate cancer, colorectal cancer, and lung cancer in France.
METHODS: The study included data from the French Network of Cancer Registries from 205,562 patients aged <75 years who were diagnosed with cancer between 1989 and 1997. The conditional probabilities of death were calculated by using a relative survival regression model in which age was included as a covariate.
RESULTS: After the first year and until 10 years after diagnosis, the annual probability of death decreased dramatically for colorectal cancer: It was the same in all age groups after 3 years, and it was approximately 1% at 10 years. For prostate cancer, the decrease was not as great, and the conditional probability of death remained higher among younger patients at >4% at 10 years. During the 3 years after diagnosis, the probability of death was greater for older patients with breast cancer; then, it decreased less for younger patients compared with older patients, leading to a greater conditional probability of death among younger patients at 4 years and up to 10 years. The annual probability of death in patients with lung cancer decreased for both sexes but remained substantially higher for men than for women, reaching approximately 8% and 5%, respectively, at 10 years.
CONCLUSIONS: Further studies would facilitate a better understanding of the observed differences in relative survival within European countries. 2009 American Cancer Society.

Entities:  

Mesh:

Year:  2009        PMID: 19569252     DOI: 10.1002/cncr.24489

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Clinical outcome of rectal cancer in patients ≥ 80 years treated in southern France (PACA region) between 2002 and 2005.

Authors:  O Guerin; J Gal; E Francois; B Jacqueme; V Sciortino; J P Gerard
Journal:  Strahlenther Onkol       Date:  2012-03-14       Impact factor: 3.621

2.  Conditional disease-free survival after surgical resection of gastrointestinal stromal tumors: a multi-institutional analysis of 502 patients.

Authors:  Danielle A Bischof; Yuhree Kim; Rebecca Dodson; M Carolina Jimenez; Ramy Behman; Andrei Cocieru; Sarah B Fisher; Ryan T Groeschl; Malcolm H Squires; Shishir K Maithel; Dan G Blazer; David A Kooby; T Clark Gamblin; Todd W Bauer; Fayez A Quereshy; Paul J Karanicolas; Calvin H L Law; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2015-04       Impact factor: 14.766

3.  Conditional survival in patients with thyroid cancer.

Authors:  Mousumi Banerjee; Daniel G Muenz; Francis P Worden; Sandra L Wong; Megan R Haymart
Journal:  Thyroid       Date:  2014-12       Impact factor: 6.568

4.  Conditional relative survival among long-term survivors of adolescent and young adult cancers.

Authors:  Chelsea Anderson; Andrew B Smitherman; Hazel B Nichols
Journal:  Cancer       Date:  2018-05-09       Impact factor: 6.860

5.  Conditional biochemical recurrence-free survival after radical prostatectomy in patients with high-risk prostate cancer.

Authors:  Sung-Woo Park; Dae Sung Hwang; Won Hoon Song; Jong Kil Nam; Hyun Jung Lee; Moon Kee Chung
Journal:  Prostate Int       Date:  2020-08-06

6.  Association of Race, Ethnicity, and Socioeconomic Status With Esthesioneuroblastoma Presentation, Treatment, and Survival.

Authors:  Rahul K Sharma; Alexandria L Irace; Jonathan B Overdevest; Justin H Turner; Zara M Patel; David A Gudis
Journal:  OTO Open       Date:  2022-02-09

7.  Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignancies.

Authors:  A M Vanderwalde; C-L Sun; L Laddaran; L Francisco; S Armenian; J Berano-Teh; F L Wong; L Popplewell; G Somlo; A S Stein; A Nademanee; A Krishnan; N Kogut; S J Forman; S Bhatia
Journal:  Leukemia       Date:  2012-11-07       Impact factor: 11.528

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.